ATLANTA, GA – – (Globe Newswire – October 31, 2024) – – A shareholder class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company’s business, operations, and prospects, including allegations that: (i) lower-than-expected production yields and component supplier shortages of key components were causing production delays for Mynaric’s CONDOR Mk3 product; (ii) the foregoing issues were likely to have a material negative impact on Mynaric’s revenue growth and cause the Company to incur an operating loss; (iii) as a result, Mynaric was unlikely to meet its own previously issued financial guidance for FY 2024; and (iv) accordingly, the Company’s business and/or financial prospects were overstated.

If you bought shares of Mynaric between June 20, 2024 and October 7, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/mynaric/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is December 30, 2024.